Shiyam Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shiyam Kumar has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Nehal Masood
Department of medicine, Section of Hematology and Oncology, The Aga Khan University Hospital, Karachi, Pakistan
9 shared publications- Asim Jamal Shaikh
Sultan Qaboos Comprehensive Cancer Care and Research Centre (SQCCCRC) Muscat, Oman
8 shared publications Muhammad Furrukh
Department of Radiation Oncology, Shifa Cancer Center, Islamabad, Pakistan
7 shared publicationsIkram A. Burney
Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman
6 shared publicationsIkram A Burney
Department of Medicine, Sultan Qaboos University Hospital, Muscat, Oman
4 shared publicationsKhawaja F. Zahid
Oncology Department, Castle Hill Hospital, Cottingham, East Riding of Yorkshire, UK
4 shared publications
Latest Publications
- 11 August 2021
- Published by Springer Nature in Journal of Religion and Health
- Vol. 61 (2) , 1351-1365
Beliefs and Perceptions About Cancer Diagnosis and Treatment-Seeking and Decision-Making Behaviors Among Omani Patients with Cancer: A Single-Center Study
A cancer diagnosis is associated with anxiety and psychological distress. Cultural and societal factors greatly affect the complex process of coping mechanisms and decision making. Omani patients receiving cancer treatment at Sultan Qaboos University Hospital in Oman were interviewed about their perceptions regarding cancer, treatment, outcome, and decision making. Out of a total of 360 approached, 216 patients consented. The median age was 42 years. The results showed that 60.6% of patients considered cancer diagnosis as a test from God, 13.9% considered it as a result of an evil eye, 40% believed prayers treat cancer. Fifty-six percent of participants wanted to make treatment decisions themselves, while 2.3% preferred their family to make decisions. Our findings suggest that perceptions about cancer in Oman are specific and are associated with religion and sociocultural background.
- 11 August 2021
- Published by Springer Nature in Journal of Religion and Health
- Vol. 61 (2) , 1351-1365
Beliefs and Perceptions About Cancer Diagnosis and Treatment-Seeking and Decision-Making Behaviors Among Omani Patients with Cancer: A Single-Center Study
A cancer diagnosis is associated with anxiety and psychological distress. Cultural and societal factors greatly affect the complex process of coping mechanisms and decision making. Omani patients receiving cancer treatment at Sultan Qaboos University Hospital in Oman were interviewed about their perceptions regarding cancer, treatment, outcome, and decision making. Out of a total of 360 approached, 216 patients consented. The median age was 42 years. The results showed that 60.6% of patients considered cancer diagnosis as a test from God, 13.9% considered it as a result of an evil eye, 40% believed prayers treat cancer. Fifty-six percent of participants wanted to make treatment decisions themselves, while 2.3% preferred their family to make decisions. Our findings suggest that perceptions about cancer in Oman are specific and are associated with religion and sociocultural background.
- Open Access
- 15 March 2021
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 21 (1) , e103-109
Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
Objectives: Totally implantable central venous access ports (port-a-caths) are increasingly used for the safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the researchers’ experiences. Methods: This retrospective follow-up study included patients who had received cancer treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the port-a-cath were recorded. Results: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P <0.05). On multivariate analysis, however, none of the factors was found to be significant. Conclusion: Infection was the most common complication necessitating port-a-cath removal. The infection rate was much lower than the researchers’ previous experience and compares favorably with several published reports.
- 15 March 2021
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 21 (1) , e103-109
Open AccessComplications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman
Objectives: Totally implantable central venous access ports (port-a-caths) are increasingly used for the safe administration of chemotherapy; however, their use is associated with complications. This study reviews patterns of complications, reasons for premature removal and the duration of the use of port-a-caths in patients receiving cancer treatment at Sultan Qaboos University Hospital (SQUH) and compares the infection rate with the literature and the researchers’ experiences. Methods: This retrospective follow-up study included patients who had received cancer treatment through a port-a-cath and were admitted to SQUH between January 2007 and April 2019. Demographic features, underlying diagnosis, clinical stage, treatment, duration of use and the cause of premature removal of the port-a-cath were recorded. Results: A total of 516 port-a-caths were inserted in 482 cancer patients. The majority of devices were implanted by interventional radiologists (n = 459; 89.0%) and the right internal jugular vein was most frequently accessed (n = 396; 76.7%). The mean indwelling time of a port-a-cath was 288 days (range: 3–1,872 days) for patients with complications and 550 days (range: 7–3,123 days) for patients without complications. Port-a-cath-related infection was the main complication (n = 63; 12.2%). Patient age, gender, treatment intent, underlying diagnosis, clinical stage, chemotherapy regimen, number of treatment courses, operator implanting the port, the type of micro-organism isolated from the port-a-cath and body mass index were significant factors affecting catheter indwelling time (P <0.05). On multivariate analysis, however, none of the factors was found to be significant. Conclusion: Infection was the most common complication necessitating port-a-cath removal. The infection rate was much lower than the researchers’ previous experience and compares favorably with several published reports.
- Open Access
- 6 July 2020
- Published by Taylor & Francis in Arab Journal of Urology
- Vol. 18 (4) , 219-225
Clinicopathological features, treatment and outcome of Omani patients with localised prostate cancer
To report the outcomes of Omani men diagnosed with localised prostate cancer (PCa), as PCa incidence is increasing in developing countries and there are scarce data regarding clinicopathological fe...
- 6 July 2020
- Published by Taylor & Francis in Arab Journal of Urology
- Vol. 18 (4) , 219-225
Open AccessClinicopathological features, treatment and outcome of Omani patients with localised prostate cancer
To report the outcomes of Omani men diagnosed with localised prostate cancer (PCa), as PCa incidence is increasing in developing countries and there are scarce data regarding clinicopathological fe...
- Open Access
- 17 September 2019
- Published by Oman Medical Journal in Oman Medical Journal
- Vol. 34 (5) , 412-419
Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital
Breast cancer (BC) is the leading cancer among women. Almost 20% of patients develop brain metastases (BM) and die shortly afterward. There is a dearth of data on the survival outcome of BC patients with BM from the Arab world. Consecutive women diagnosed with BC who developed radiologically-confirmed BM during their illness were identified through the hospital's electronic patient's records. Clinicopathological features and treatment outcomes were recorded. Survival was calculated using the Kaplan-Meier method, and factors affecting survival were studied using log-rank analysis. Between January 2003 and June 2015, a total of 692 patients were treated for BC at our institute. Forty-eight (6.9%) developed BM. The median age at the diagnosis of BM was 45.2 years. More than half of cohort (54.2%) had HER2 positive disease, while 27.1% had the triple-negative disease. The median time interval between the diagnosis of BC and the development of BM was 21 months, and median survival after development of brain disease was seven months. On univariate analysis, pathological grade, previous systemic treatment, brain as the first site of metastases, brain as the only site of metastases, treatment of BM, systemic treatment after BM, and diagnosis-specific graded prognostic assessment (DS-GPA) score significantly affected survival. On multivariate Cox regression analysis, the brain as the first site of metastases, treatment for brain disease, treatment type, and DS-GPA score significantly affected survival post-BM. Our data indicate that Omani women are diagnosed with BC at a younger age, develop BM earlier, and carry a poor outcome.
- 17 September 2019
- Published by Oman Medical Journal in Oman Medical Journal
- Vol. 34 (5) , 412-419
Open AccessOutcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital
Breast cancer (BC) is the leading cancer among women. Almost 20% of patients develop brain metastases (BM) and die shortly afterward. There is a dearth of data on the survival outcome of BC patients with BM from the Arab world. Consecutive women diagnosed with BC who developed radiologically-confirmed BM during their illness were identified through the hospital's electronic patient's records. Clinicopathological features and treatment outcomes were recorded. Survival was calculated using the Kaplan-Meier method, and factors affecting survival were studied using log-rank analysis. Between January 2003 and June 2015, a total of 692 patients were treated for BC at our institute. Forty-eight (6.9%) developed BM. The median age at the diagnosis of BM was 45.2 years. More than half of cohort (54.2%) had HER2 positive disease, while 27.1% had the triple-negative disease. The median time interval between the diagnosis of BC and the development of BM was 21 months, and median survival after development of brain disease was seven months. On univariate analysis, pathological grade, previous systemic treatment, brain as the first site of metastases, brain as the only site of metastases, treatment of BM, systemic treatment after BM, and diagnosis-specific graded prognostic assessment (DS-GPA) score significantly affected survival. On multivariate Cox regression analysis, the brain as the first site of metastases, treatment for brain disease, treatment type, and DS-GPA score significantly affected survival post-BM. Our data indicate that Omani women are diagnosed with BC at a younger age, develop BM earlier, and carry a poor outcome.
- Open Access
- 11 May 2019
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 19 (3) , e209-216
Outcomes of Women with Non-Metastatic Triple-Negative Breast Cancer in Oman: A single-centre experience
Outcomes of Women with Non-Metastatic Triple-Negative Breast Cancer in Oman: A single-centre experience
- 11 May 2019
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 19 (3) , e209-216
Open AccessOutcomes of Women with Non-Metastatic Triple-Negative Breast Cancer in Oman: A single-centre experience
Outcomes of Women with Non-Metastatic Triple-Negative Breast Cancer in Oman: A single-centre experience
- Open Access
- 10 October 2017
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 17 (3) , e301-308
Trends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital
Trends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital
- 10 October 2017
- Published by Sultan Qaboos University in Sultan Qaboos University Medical Journal
- Vol. 17 (3) , e301-308
Open AccessTrends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital
Trends and Outcomes of Non-Small-Cell Lung Cancer in Omani Patients: Experience at a university hospital
- Open Access
- 1 October 2017
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 4 (4) , 323-329
Role of systemic antibiotics in preventing epidermal growth factor receptor: Tyrosine kinase inhibitors-induced skin toxicities
- 1 October 2017
- Published by Elsevier in Asia-Pacific Journal of Oncology Nursing
- Vol. 4 (4) , 323-329
Open AccessRole of systemic antibiotics in preventing epidermal growth factor receptor: Tyrosine kinase inhibitors-induced skin toxicities
- Open Access
- 1 January 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-10
Calpain-1 Expression in Triple-Negative Breast Cancer: A Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index
Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer in which calpain system plays an important role in its cellular processes including apoptosis and proliferation. Although such roles have been assessed in tumor pathogenesis, the correlation of its expression to the proliferating/apoptotic index has not been studied yet. Immunohistochemical staining of calpain-1 was performed on paraffin-embedded tissues to correlate its expression with clinicopathological variables and outcome. The proliferation activity was determined by calculating the percentage of cells expressing the Ki-67 antigen. The apoptotic index was assessed morphologically and biochemically using Haematoxylin & Eosin method and Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay, respectively. Calpain-1 was significantly expressed in TNBC tissues varying from low to high with a significant correlation to lymph node status but not with the other clinicopathological variables, suggesting its role as a prognostic factor. In addition, a positive correlation was found between both apoptotic counts assays (, ) as well as with proliferation (). Calpain-1 expression had no significant correlation with either proliferation () or apoptotic indices ( and ). Determining calpain-1 expression may provide relevant prognostic value for TNBC cancer patients.- 1 January 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-10
Open AccessCalpain-1 Expression in Triple-Negative Breast Cancer: A Potential Prognostic Factor Independent of the Proliferative/Apoptotic Index
Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer in which calpain system plays an important role in its cellular processes including apoptosis and proliferation. Although such roles have been assessed in tumor pathogenesis, the correlation of its expression to the proliferating/apoptotic index has not been studied yet. Immunohistochemical staining of calpain-1 was performed on paraffin-embedded tissues to correlate its expression with clinicopathological variables and outcome. The proliferation activity was determined by calculating the percentage of cells expressing the Ki-67 antigen. The apoptotic index was assessed morphologically and biochemically using Haematoxylin & Eosin method and Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay, respectively. Calpain-1 was significantly expressed in TNBC tissues varying from low to high with a significant correlation to lymph node status but not with the other clinicopathological variables, suggesting its role as a prognostic factor. In addition, a positive correlation was found between both apoptotic counts assays (, ) as well as with proliferation (). Calpain-1 expression had no significant correlation with either proliferation () or apoptotic indices ( and ). Determining calpain-1 expression may provide relevant prognostic value for TNBC cancer patients. - 1 January 2016
- Published by Medknow in Indian Journal of Cancer
- Vol. 53 (2) , 230-234
Presenting features, treatment patterns and outcomes of patients with breast cancer in Pakistan: Experience at a university hospital
Background: Breast cancer is the most common cancer in Pakistani women. We report the presenting features, treatment patterns and survival of breast cancer from a University Hospital in Southern Pakistan and compare the data with international population based studies. Materials and Methods: Medical records of patients diagnosed to have breast cancer between January 1999 and November 2008 were reviewed retrospectively. Results: A total of 845 patients were identified. Median age of diagnosis was 48 years (range 18-92). Clinical stage was as follows: Stage I 9.9%; Stage II 48.5%; Stage III 26.2%; Stage IV 13.8%; data not available 1.5%. Approximately, half (51.6%) were estrogen receptor (ER) positive and 17.5% over-expressed Her2/neu. Nearly 23% patients received neo-adjuvant chemotherapy while 68.9% received adjuvant chemotherapy. Anthracycline based treatment was the most common treatment until 2003 while later on, patients also received taxanes and trastuzumab based therapy. Age, stage, tumor size, lymph node status, tumor grade, ER status, treatment with hormonal therapy and radiation were the major predictive factors for overall survival (OS). We report an impressive 5 year OS of 75%, stage specific survival was 100%, 88% and 58% for Stages I, II and III respectively. Conclusion: The majority of patients present at a younger age and with locally advanced disease. However, short term follow-up reveals that the outcomes are comparable with the published literature from developed countries. Long-term follow-up and inclusion of data from population-based registries are required for accurate comparison.
- 1 January 2016
- Published by Medknow in Indian Journal of Cancer
- Vol. 53 (2) , 230-234
Presenting features, treatment patterns and outcomes of patients with breast cancer in Pakistan: Experience at a university hospital
Background: Breast cancer is the most common cancer in Pakistani women. We report the presenting features, treatment patterns and survival of breast cancer from a University Hospital in Southern Pakistan and compare the data with international population based studies. Materials and Methods: Medical records of patients diagnosed to have breast cancer between January 1999 and November 2008 were reviewed retrospectively. Results: A total of 845 patients were identified. Median age of diagnosis was 48 years (range 18-92). Clinical stage was as follows: Stage I 9.9%; Stage II 48.5%; Stage III 26.2%; Stage IV 13.8%; data not available 1.5%. Approximately, half (51.6%) were estrogen receptor (ER) positive and 17.5% over-expressed Her2/neu. Nearly 23% patients received neo-adjuvant chemotherapy while 68.9% received adjuvant chemotherapy. Anthracycline based treatment was the most common treatment until 2003 while later on, patients also received taxanes and trastuzumab based therapy. Age, stage, tumor size, lymph node status, tumor grade, ER status, treatment with hormonal therapy and radiation were the major predictive factors for overall survival (OS). We report an impressive 5 year OS of 75%, stage specific survival was 100%, 88% and 58% for Stages I, II and III respectively. Conclusion: The majority of patients present at a younger age and with locally advanced disease. However, short term follow-up reveals that the outcomes are comparable with the published literature from developed countries. Long-term follow-up and inclusion of data from population-based registries are required for accurate comparison.